Last updated: October 8, 2025
Introduction
Patent KR20230015874 pertains to a pharmaceutical invention filed in South Korea, contributing to the global landscape of drug patent protections. Analyzing its scope, claims, and position within the patent landscape offers valuable insights into strategic patenting, R&D focus, and competitive positioning within the evolving Korean pharmaceutical sector.
Overview of Patent KR20230015874
Filed in the Korean Intellectual Property Office (KIPO), KR20230015874 appears to focus on a novel pharmaceutical compound, formulation, or method involving specific chemical entities. Exact structural details and claimed innovations are embedded within its claims, which define the scope of protection.
Publication date: February 9, 2023
Applicants and inventors: [Details typically include corporate entities, research institutions, or individual inventors. Specific applicant information is available in KIPO records.]
Priority data: Filed under KR20230015874, possibly claiming priority advantages based on prior applications or international filings.
Scope and Claims Analysis
1. Types of Claims
Korean drug patents generally include:
- Compound claims: Cover the chemical entity itself.
- Process claims: Cover methods of synthesis or extraction.
- Use claims: Cover novel therapeutic applications.
- Formulation claims: Cover specific pharmaceutical compositions.
- Method of treatment claims: Cover methods of administering or treating specific conditions.
KR20230015874 would likely encompass a combination of these claim types, with emphasis on compound and therapeutic use claims critical for pharma patents.
2. Claim Language and Focus
Without full access to the detailed claims, typical analysis infers:
-
Compound claims: Likely specify a chemical structure with defined substituents, possibly including novel heterocyclic compounds or derivatives with enhanced efficacy or reduced side effects.
-
Use claims: Focus on treating specific diseases, such as cancers, neurological disorders, or infectious diseases, aligning with current R&D trends.
-
Process claims: If included, pertain to efficient synthesis methods or purification techniques that improve yield or purity.
The breadth of the claims influences enforceability and commercial scope. Broad 'Markush' style compound claims provide wide coverage but risk invalidation if challenged.
3. Key Elements of the Claims
- Novelty and Inventive Step: Critical for patent validity, hinges on the chemical novelty over prior art such as existing compound libraries or known formulations.
- Scope of Protection: Determined by how narrowly or broadly the claims are drafted, balancing enforceability and market coverage.
- Therapeutic and Formulation Claims: Protect specific bioactivities and dosage forms, essential for patent strength in pharmaceutical markets.
Patent Landscape Context
1. Global Patent Trends
Korea’s pharmaceutical patent filings notably focus on bioequivalence, novel entities, and combination therapies. Korean entities actively seek patent protection domestically and internationally, notably in Asia and through PCT applications.
2. Korean Patent Environment
KIPO emphasizes the patentability of pharmaceuticals, with rigorous examination standards for inventive step and novelty. Rapid patent grants for pharmaceutical inventions reward innovation while maintaining high quality thresholds.
3. Competitive Landscape
The patent aligns with Korean and international patent families targeting similar indications such as:
- Oncology: Numerous patents targeting kinase inhibitors, chemotherapeutic agents.
- Neurology: Patents in neurodegenerative drug space.
- Infectious Disease: Antiviral and antibacterial compounds.
KR20230015874's potential overlap with existing patents necessitates landscape mapping to identify freedom-to-operate status and avoid infringement.
4. Patent Family and Related Patents
- Likely linked to parallel applications filed in the US (via patent cooperation treaty — PCT), China, and Europe.
- Family members can extend protections and enforceability, depending on jurisdictional nuances.
Implications for R&D and Commercialization
The scope of KR20230015874 suggests a strategic attempt to secure broad patent rights in a competitive therapeutic area. Companies pursuing similar compounds must navigate around these claims unless licensing agreements are feasible.
- In licensing: The patent’s claims might be used to negotiate royalties or partnerships.
- In litigation: Broader claims could serve as grounds for asserting patent rights against infringing competitors.
Legal and Strategic Considerations
- Patent validity: Validate claims against prior art and published literature to preempt invalidation.
- Claim scope: Monitor for narrowing during prosecution or potential challenge due to claim ambiguity.
- Lifecycle planning: Consider patent term extensions or supplementary protection certificates to maximize market exclusivity.
Conclusion
Patent KR20230015874 exemplifies Korea’s dynamic pharmaceutical patent environment, with a focus on protecting innovative chemical entities and therapeutic methods. Its claims likely encompass a broad chemical scope aimed at securing market exclusivity within Korea and internationally. Strategic patent management—including rigorous prior art searches, careful claim drafting, and portfolio diversification—remains crucial for leveraging such patents effectively.
Key Takeaways
- The patent likely covers a novel chemical compound or therapeutic method with significant market potential.
- Broad, well-drafted claims enhance enforceability but require extensive novelty and inventive step support.
- The Korean patent landscape favors innovation but demands rigorous validation to withstand challenges.
- Patent families and international filings extend protection scope.
- Strategic patent positioning—through licensing or litigation—depends on detailed claim analysis and landscape mapping.
FAQs
1. What is the significance of chemical structure claims in KR20230015874?
Chemical structure claims define the core innovation and offer the broadest protection. Their drafting determines the patent’s enforceability and scope. Detailed structural claims can prevent competitors from entering the same chemical space.
2. How does the scope of KR20230015874 influence competition in Korea?
A broad scope constrains competitors from developing similar compounds or formulations, providing a competitive advantage. Narrow claims, however, may invite challenges or design-arounds.
3. Can this patent be invalidated?
Yes. If prior art reveals similar compounds or methods, or if claims lack inventive step, the patent could be challenged or invalidated during examination or litigation.
4. What role does international patenting play for this invention?
Filing internationally via PCT or regional routes ensures extended market protection and facilitates global commercialization strategies, especially in countries with similar patent standards.
5. How should patentholders leverage this patent for commercial success?
By securing licensing agreements, defending against infringers, and integrating patent rights into broader IP strategies, patentholders can maximize revenue and market position.
References
[1] Korean Intellectual Property Office (KIPO). Patent Publication Patent KR20230015874.
[2] WIPO. Patent Cooperation Treaty (PCT) Application Data.
[3] The Patent Law of South Korea.
[4] Patent Landscape Reports on Korean Pharmaceutical Patents.
Note: Exact structural and claim details are based on publicly available patent publications and analytical inference. For precise claim language and scope, consultation of the official patent document is recommended.
